{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T20:10:08Z","timestamp":1778962208702,"version":"3.51.4"},"publisher-location":"New York, NY","reference-count":53,"publisher":"Springer US","isbn-type":[{"value":"9781071647370","type":"print"},{"value":"9781071647387","type":"electronic"}],"license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-1-0716-4738-7_16","type":"book-chapter","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:32:57Z","timestamp":1759271577000},"page":"213-223","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Digital Outcome Measures for Gait and Spontaneous Locomotor Activity in Dystrophic Dogs"],"prefix":"10.1007","author":[{"given":"Mutsuki","family":"Kuraoka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Kawashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Nitahara-Kasahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisateru","family":"Tachimori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin\u2019ichi","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsura","family":"Minegishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitsugu","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,1]]},"reference":[{"issue":"2","key":"16_CR1","doi-asserted-by":"publisher","first-page":"138","DOI":"10.5435\/00124635-200203000-00009","volume":"10","author":"M Sussman","year":"2002","unstructured":"Sussman M (2002) Duchenne muscular dystrophy. J Am Acad Orthop Surg 10(2):138\u2013151","journal-title":"J Am Acad Orthop Surg"},{"issue":"1","key":"16_CR2","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/mus.880170103","volume":"17","author":"K Matsumura","year":"1994","unstructured":"Matsumura K, Campbell KP (1994) Dystrophin-glycoprotein complex: its role in the molecular pathogenesis of muscular dystrophies. Muscle Nerve 17(1):2\u201315. https:\/\/doi.org\/10.1002\/mus.880170103","journal-title":"Muscle Nerve"},{"issue":"9","key":"16_CR3","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.braindev.2016.04.001","volume":"38","author":"M Goto","year":"2016","unstructured":"Goto M et al (2016) Long-term outcomes of steroid therapy for Duchenne muscular dystrophy in Japan. Brain Dev 38(9):785\u2013791. https:\/\/doi.org\/10.1016\/j.braindev.2016.04.001","journal-title":"Brain Dev"},{"key":"16_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003725.pub3","volume":"1","author":"AY Manzur","year":"2008","unstructured":"Manzur AY, Kuntzer T, Pike M, Swan A (2008) Glucocorticoid corticosteroids for Duchenne muscular dystrophy. Cochrane Database Syst Rev 1:CD003725. https:\/\/doi.org\/10.1002\/14651858.CD003725.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"16_CR5","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1146\/annurev-genom-090314-025003","volume":"16","author":"S Guiraud","year":"2015","unstructured":"Guiraud S et al (2015) The pathogenesis and therapy of muscular dystrophies. Annu Rev Genomics Hum Genet 16:281\u2013308. https:\/\/doi.org\/10.1146\/annurev-genom-090314-025003","journal-title":"Annu Rev Genomics Hum Genet"},{"issue":"5","key":"16_CR6","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1097\/WCO.0000000000000243","volume":"28","author":"PB Shieh","year":"2015","unstructured":"Shieh PB (2015) Duchenne muscular dystrophy: clinical trials and emerging tribulations. Curr Opin Neurol 28(5):542\u2013546. https:\/\/doi.org\/10.1097\/WCO.0000000000000243","journal-title":"Curr Opin Neurol"},{"issue":"5","key":"16_CR7","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000208112","volume":"102","author":"UJ Dang","year":"2024","unstructured":"Dang UJ et al (2024) Efficacy and safety of Vamorolone over 48 weeks in boys with Duchenne muscular dystrophy: a randomized controlled trial. Neurology 102(5):e208112. https:\/\/doi.org\/10.1212\/WNL.0000000000208112","journal-title":"Neurology"},{"issue":"4","key":"16_CR8","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/S1474-4422(24)00036-X","volume":"23","author":"E Mercuri","year":"2024","unstructured":"Mercuri E et al (2024) Safety and efficacy of givinostat in boys with Duchenne muscular dystrophy (EPIDYS): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Neurol 23(4):393\u2013403. https:\/\/doi.org\/10.1016\/S1474-4422(24)00036-X","journal-title":"Lancet Neurol"},{"issue":"1","key":"16_CR9","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/s41591-024-03304-z","volume":"31","author":"JR Mendell","year":"2025","unstructured":"Mendell JR et al (2025) AAV gene therapy for Duchenne muscular dystrophy: the EMBARK phase 3 randomized trial. Nat Med 31(1):332\u2013341. https:\/\/doi.org\/10.1038\/s41591-024-03304-z","journal-title":"Nat Med"},{"issue":"9","key":"16_CR10","doi-asserted-by":"publisher","first-page":"4057","DOI":"10.1007\/s00431-024-05670-9","volume":"183","author":"BC Henzi","year":"2024","unstructured":"Henzi BC et al (2024) Tamoxifen may contribute to preserve cardiac function in Duchenne muscular dystrophy. Eur J Pediatr 183(9):4057\u20134062. https:\/\/doi.org\/10.1007\/s00431-024-05670-9","journal-title":"Eur J Pediatr"},{"issue":"1","key":"16_CR11","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3988\/jcn.2024.0299","volume":"21","author":"J Lee","year":"2025","unstructured":"Lee J et al (2025) Safety and tolerability of Wharton\u2019s jelly-derived mesenchymal stem cells for patients with Duchenne muscular dystrophy: a phase 1 clinical study. J Clin Neurol 21(1):40\u201352. https:\/\/doi.org\/10.3988\/jcn.2024.0299","journal-title":"J Clin Neurol"},{"issue":"1","key":"16_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101901","volume":"6","author":"H Komaki","year":"2025","unstructured":"Komaki H et al (2025) Phase 1\/2 trial of brogidirsen: dual-targeting antisense oligonucleotides for exon 44 skipping in Duchenne muscular dystrophy. Cell Rep Med 6(1):101901. https:\/\/doi.org\/10.1016\/j.xcrm.2024.101901","journal-title":"Cell Rep Med"},{"issue":"3","key":"16_CR13","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1002\/mus.23902","volume":"48","author":"CM McDonald","year":"2013","unstructured":"McDonald CM et al (2013) The 6-minute walk test and other endpoints in Duchenne muscular dystrophy: longitudinal natural history observations over 48 weeks from a multicenter study. Muscle Nerve 48(3):343\u2013356. https:\/\/doi.org\/10.1002\/mus.23902","journal-title":"Muscle Nerve"},{"issue":"3","key":"16_CR14","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1002\/mus.23905","volume":"48","author":"CM McDonald","year":"2013","unstructured":"McDonald CM et al (2013) The 6-minute walk test and other clinical endpoints in duchenne muscular dystrophy: reliability, concurrent validity, and minimal clinically important differences from a multicenter study. Muscle Nerve 48(3):357\u2013368. https:\/\/doi.org\/10.1002\/mus.23905","journal-title":"Muscle Nerve"},{"issue":"6","key":"16_CR15","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.ejpn.2005.06.004","volume":"9","author":"EA Beenakker","year":"2005","unstructured":"Beenakker EA et al (2005) Functional ability and muscle force in healthy children and ambulant Duchenne muscular dystrophy patients. Eur J Paediatr Neurol 9(6):387\u2013393. https:\/\/doi.org\/10.1016\/j.ejpn.2005.06.004","journal-title":"Eur J Paediatr Neurol"},{"issue":"7","key":"16_CR16","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.nmd.2009.06.368","volume":"19","author":"ES Mazzone","year":"2009","unstructured":"Mazzone ES et al (2009) Reliability of the north star ambulatory assessment in a multicentric setting. Neuromuscul Disord 19(7):458\u2013461. https:\/\/doi.org\/10.1016\/j.nmd.2009.06.368","journal-title":"Neuromuscul Disord"},{"issue":"2","key":"16_CR17","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/dmcn.13590","volume":"60","author":"A Schreiber","year":"2018","unstructured":"Schreiber A et al (2018) Corticosteroids in Duchenne muscular dystrophy: impact on the motor function measure sensitivity to change and implications for clinical trials. Dev Med Child Neurol 60(2):185\u2013191. https:\/\/doi.org\/10.1111\/dmcn.13590","journal-title":"Dev Med Child Neurol"},{"issue":"3","key":"16_CR18","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.nmd.2013.11.014","volume":"24","author":"M Pane","year":"2014","unstructured":"Pane M et al (2014) Reliability of the performance of upper limb assessment in Duchenne muscular dystrophy. Neuromuscul Disord 24(3):201\u2013206. https:\/\/doi.org\/10.1016\/j.nmd.2013.11.014","journal-title":"Neuromuscul Disord"},{"key":"16_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2014.6","volume":"3","author":"QL Lu","year":"2014","unstructured":"Lu QL, Cirak S, Partridge T (2014) What can we learn from clinical trials of exon skipping for DMD? Mol Ther Nucleic Acids 3:e152. https:\/\/doi.org\/10.1038\/mtna.2014.6","journal-title":"Mol Ther Nucleic Acids"},{"key":"16_CR20","doi-asserted-by":"publisher","unstructured":"Gonzalez Barral C, Servais L (2024) Digital outcome measures in Duchene muscular dystrophy: lessons learnt from clinical trials. J Neuromuscul Dis:22143602241296280. https:\/\/doi.org\/10.1177\/22143602241296280","DOI":"10.1177\/22143602241296280"},{"key":"16_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.916714","volume":"13","author":"E Ferrer-Mallol","year":"2022","unstructured":"Ferrer-Mallol E et al (2022) Patient-led development of digital endpoints and the use of computer vision analysis in assessment of motor function in rare diseases. Front Pharmacol 13:916714. https:\/\/doi.org\/10.3389\/fphar.2022.916714","journal-title":"Front Pharmacol"},{"issue":"3","key":"16_CR22","doi-asserted-by":"publisher","first-page":"701","DOI":"10.3233\/JND-230188","volume":"11","author":"M Rabbia","year":"2024","unstructured":"Rabbia M et al (2024) Stride velocity 95th centile detects decline in ambulatory function over shorter intervals than the 6-minute walk test or north star ambulatory assessment in Duchenne muscular dystrophy. J Neuromuscul Dis 11(3):701\u2013714. https:\/\/doi.org\/10.3233\/JND-230188","journal-title":"J Neuromuscul Dis"},{"issue":"10","key":"16_CR23","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1038\/s41591-023-02459-5","volume":"29","author":"L Servais","year":"2023","unstructured":"Servais L et al (2023) First regulatory qualification of a digital primary endpoint to measure treatment efficacy in DMD. Nat Med 29(10):2391\u20132392. https:\/\/doi.org\/10.1038\/s41591-023-02459-5","journal-title":"Nat Med"},{"issue":"10","key":"16_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0048182","volume":"7","author":"JM Neugebauer","year":"2012","unstructured":"Neugebauer JM, Hawkins DA, Beckett L (2012) Estimating youth locomotion ground reaction forces using an accelerometer-based activity monitor. PLoS One 7(10):e48182. https:\/\/doi.org\/10.1371\/journal.pone.0048182","journal-title":"PLoS One"},{"issue":"1","key":"16_CR25","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1249\/MSS.0000000000000394","volume":"47","author":"AV Rowlands","year":"2015","unstructured":"Rowlands AV et al (2015) Comparability of measured acceleration from accelerometry-based activity monitors. Med Sci Sports Exerc 47(1):201\u2013210. https:\/\/doi.org\/10.1249\/MSS.0000000000000394","journal-title":"Med Sci Sports Exerc"},{"issue":"12","key":"16_CR26","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1109\/TBME.2007.896591","volume":"54","author":"A Salarian","year":"2007","unstructured":"Salarian A et al (2007) Ambulatory monitoring of physical activities in patients with Parkinson\u2019s disease. IEEE Trans Biomed Eng 54(12):2296\u20132299","journal-title":"IEEE Trans Biomed Eng"},{"issue":"1","key":"16_CR27","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1177\/0883073811413581","volume":"27","author":"R Ganea","year":"2012","unstructured":"Ganea R et al (2012) Gait assessment in children with duchenne muscular dystrophy during long-distance walking. J Child Neurol 27(1):30\u201338. https:\/\/doi.org\/10.1177\/0883073811413581","journal-title":"J Child Neurol"},{"issue":"3","key":"16_CR28","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1177\/0883073814530502","volume":"30","author":"ZE Davidson","year":"2015","unstructured":"Davidson ZE et al (2015) Strong correlation between the 6-minute walk test and accelerometry functional outcomes in boys with Duchenne muscular dystrophy. J Child Neurol 30(3):357\u2013363. https:\/\/doi.org\/10.1177\/0883073814530502","journal-title":"J Child Neurol"},{"issue":"6","key":"16_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0156696","volume":"11","author":"AG Le Moing","year":"2016","unstructured":"Le Moing AG et al (2016) A movement monitor based on magneto-inertial sensors for non-ambulant patients with Duchenne muscular dystrophy: a pilot study in controlled environment. PLoS One 11(6):e0156696. https:\/\/doi.org\/10.1371\/journal.pone.0156696","journal-title":"PLoS One"},{"issue":"5","key":"16_CR30","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1111\/ped.12348","volume":"56","author":"S Kimura","year":"2014","unstructured":"Kimura S et al (2014) Estimation of muscle strength from actigraph data in Duchenne muscular dystrophy. Pediatr Int 56(5):748\u2013752. https:\/\/doi.org\/10.1111\/ped.12348","journal-title":"Pediatr Int"},{"key":"16_CR31","doi-asserted-by":"publisher","unstructured":"Ramli AA et al (2024) Gait characterization in Duchenne muscular dystrophy (DMD) using a single-sensor accelerometer: classical machine learning and deep learning approaches. Sensors (Basel) 24(4). https:\/\/doi.org\/10.3390\/s24041123","DOI":"10.3390\/s24041123"},{"issue":"1","key":"16_CR32","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ejpn.2010.07.002","volume":"15","author":"PY Jeannet","year":"2011","unstructured":"Jeannet PY et al (2011) Continuous monitoring and quantification of multiple parameters of daily physical activity in ambulatory Duchenne muscular dystrophy patients. Eur J Paediatr Neurol 15(1):40\u201347. https:\/\/doi.org\/10.1016\/j.ejpn.2010.07.002","journal-title":"Eur J Paediatr Neurol"},{"issue":"11","key":"16_CR33","doi-asserted-by":"publisher","first-page":"3249","DOI":"10.1589\/jpts.28.3249","volume":"28","author":"H Nishizawa","year":"2016","unstructured":"Nishizawa H, Shiba N, Nakamura A (2016) Usefulness of continuous actigraph monitoring in the assessment of the effect of corticosteroid treatment for Duchenne muscular dystrophy: a case report. J Phys Ther Sci 28(11):3249\u20133251. https:\/\/doi.org\/10.1589\/jpts.28.3249","journal-title":"J Phys Ther Sci"},{"issue":"4","key":"16_CR34","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.nmd.2020.02.007","volume":"30","author":"M Killian","year":"2020","unstructured":"Killian M et al (2020) Beyond ambulation: measuring physical activity in youth with Duchenne muscular dystrophy. Neuromuscul Disord 30(4):277\u2013282. https:\/\/doi.org\/10.1016\/j.nmd.2020.02.007","journal-title":"Neuromuscul Disord"},{"issue":"1\u20132","key":"16_CR35","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s00335-011-9382-y","volume":"23","author":"JN Kornegay","year":"2012","unstructured":"Kornegay JN et al (2012) Canine models of Duchenne muscular dystrophy and their use in therapeutic strategies. Mamm Genome 23(1\u20132):85\u2013108. https:\/\/doi.org\/10.1007\/s00335-011-9382-y","journal-title":"Mamm Genome"},{"issue":"1","key":"16_CR36","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13395-017-0124-z","volume":"7","author":"JN Kornegay","year":"2017","unstructured":"Kornegay JN (2017) The golden retriever model of Duchenne muscular dystrophy. Skelet Muscle 7(1):9. https:\/\/doi.org\/10.1186\/s13395-017-0124-z","journal-title":"Skelet Muscle"},{"issue":"2","key":"16_CR37","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1538\/expanim.52.93","volume":"52","author":"Y Shimatsu","year":"2003","unstructured":"Shimatsu Y et al (2003) Canine X-linked muscular dystrophy in Japan (CXMDJ). Exp Anim 52(2):93\u201397","journal-title":"Exp Anim"},{"issue":"4","key":"16_CR38","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1538\/expanim.21-0072","volume":"70","author":"M Kuraoka","year":"2021","unstructured":"Kuraoka M, Aoki Y, Takeda S (2021) Development of outcome measures according to dystrophic phenotypes in canine X-linked muscular dystrophy in Japan. Exp Anim 70(4):419\u2013430. https:\/\/doi.org\/10.1538\/expanim.21-0072","journal-title":"Exp Anim"},{"issue":"3\u20134","key":"16_CR39","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/BF00688053","volume":"71","author":"BA Valentine","year":"1986","unstructured":"Valentine BA, Cooper BJ, Cummings JF, deLahunta A (1986) Progressive muscular dystrophy in a golden retriever dog: light microscope and ultrastructural features at 4 and 8 months. Acta Neuropathol 71(3\u20134):301\u2013310. https:\/\/doi.org\/10.1007\/BF00688053","journal-title":"Acta Neuropathol"},{"issue":"1\u20133","key":"16_CR40","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/0022-510x(88)90206-7","volume":"88","author":"BA Valentine","year":"1988","unstructured":"Valentine BA et al (1988) Canine X-linked muscular dystrophy. An animal model of Duchenne muscular dystrophy: clinical studies. J Neurol Sci 88(1\u20133):69\u201381. https:\/\/doi.org\/10.1016\/0022-510x(88)90206-7","journal-title":"J Neurol Sci"},{"issue":"2","key":"16_CR41","first-page":"145","volume":"24","author":"Y Shimatsu","year":"2005","unstructured":"Shimatsu Y et al (2005) Major clinical and histopathological characteristics of canine X-linked muscular dystrophy in Japan. CXMDJ Acta Myol 24(2):145\u2013154","journal-title":"CXMDJ Acta Myol"},{"issue":"6","key":"16_CR42","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/s0960-8966(03)00025-7","volume":"13","author":"JN Kornegay","year":"2003","unstructured":"Kornegay JN et al (2003) The cranial sartorius muscle undergoes true hypertrophy in dogs with golden retriever muscular dystrophy. Neuromuscul Disord 13(6):493\u2013500. https:\/\/doi.org\/10.1016\/s0960-8966(03)00025-7","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"16_CR43","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.nmd.2009.10.007","volume":"20","author":"AP Marsh","year":"2010","unstructured":"Marsh AP et al (2010) Kinematics of gait in golden retriever muscular dystrophy. Neuromuscul Disord 20(1):16\u201320. https:\/\/doi.org\/10.1016\/j.nmd.2009.10.007","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"16_CR44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0059875","volume":"8","author":"JH Shin","year":"2013","unstructured":"Shin JH et al (2013) Quantitative phenotyping of Duchenne muscular dystrophy dogs by comprehensive gait analysis and overnight activity monitoring. PLoS One 8(3):e59875. https:\/\/doi.org\/10.1371\/journal.pone.0059875","journal-title":"PLoS One"},{"issue":"11","key":"16_CR45","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.nmd.2009.07.014","volume":"19","author":"I Barthelemy","year":"2009","unstructured":"Barthelemy I et al (2009) Gait analysis using accelerometry in dystrophin-deficient dogs. Neuromuscul Disord 19(11):788\u2013796. https:\/\/doi.org\/10.1016\/j.nmd.2009.07.014","journal-title":"Neuromuscul Disord"},{"key":"16_CR46","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/1471-2474-12-75","volume":"12","author":"I Barthelemy","year":"2011","unstructured":"Barthelemy I et al (2011) Longitudinal ambulatory measurements of gait abnormality in dystrophin-deficient dogs. BMC Musculoskelet Disord 12:75. https:\/\/doi.org\/10.1186\/1471-2474-12-75","journal-title":"BMC Musculoskelet Disord"},{"issue":"11","key":"16_CR47","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1242\/dmm.016014","volume":"7","author":"I Barthelemy","year":"2014","unstructured":"Barthelemy I et al (2014) Predictive markers of clinical outcome in the GRMD dog model of Duchenne muscular dystrophy. Dis Model Mech 7(11):1253\u20131261. https:\/\/doi.org\/10.1242\/dmm.016014","journal-title":"Dis Model Mech"},{"issue":"1","key":"16_CR48","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s12891-017-1494-4","volume":"18","author":"B Fraysse","year":"2017","unstructured":"Fraysse B et al (2017) Gait characterization in golden retriever muscular dystrophy dogs using linear discriminant analysis. BMC Musculoskelet Disord 18(1):153. https:\/\/doi.org\/10.1186\/s12891-017-1494-4","journal-title":"BMC Musculoskelet Disord"},{"issue":"12","key":"16_CR49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0208415","volume":"13","author":"M Kuraoka","year":"2018","unstructured":"Kuraoka M et al (2018) Accelerometric outcomes of motor function related to clinical evaluations and muscle involvement in dystrophic dogs. PLoS One 13(12):e0208415. https:\/\/doi.org\/10.1371\/journal.pone.0208415","journal-title":"PLoS One"},{"issue":"4","key":"16_CR50","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/mt.2015.5","volume":"23","author":"H Hayashita-Kinoh","year":"2015","unstructured":"Hayashita-Kinoh H et al (2015) Intra-amniotic rAAV-mediated microdystrophin gene transfer improves canine X-linked muscular dystrophy and may induce immune tolerance. Mol Ther 23(4):627\u2013637. https:\/\/doi.org\/10.1038\/mt.2015.5","journal-title":"Mol Ther"},{"issue":"16","key":"16_CR51","doi-asserted-by":"publisher","first-page":"4213","DOI":"10.1073\/pnas.1613203114","volume":"114","author":"Y Echigoya","year":"2017","unstructured":"Echigoya Y et al (2017) Effects of systemic multiexon skipping with peptide-conjugated morpholinos in the heart of a dog model of Duchenne muscular dystrophy. Proc Natl Acad Sci USA 114(16):4213\u20134218. https:\/\/doi.org\/10.1073\/pnas.1613203114","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"16_CR52","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1002\/ana.21627","volume":"65","author":"T Yokota","year":"2009","unstructured":"Yokota T et al (2009) Efficacy of systemic morpholino exon-skipping in Duchenne dystrophy dogs. Ann Neurol 65(6):667\u2013676. https:\/\/doi.org\/10.1002\/ana.21627","journal-title":"Ann Neurol"},{"key":"16_CR53","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/1475-925X-13-156","volume":"13","author":"A Galan-Mercant","year":"2014","unstructured":"Galan-Mercant A, Baron-Lopez FJ, Labajos-Manzanares MT, Cuesta-Vargas AI (2014) Reliability and criterion-related validity with a smartphone used in timed-up-and-go test. Biomed Eng Online 13:156. https:\/\/doi.org\/10.1186\/1475-925X-13-156","journal-title":"Biomed Eng Online"}],"container-title":["Methods in Molecular Biology","Splice Switching"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-4738-7_16","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T20:05:45Z","timestamp":1778961945000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-4738-7_16"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,1]]},"ISBN":["9781071647370","9781071647387"],"references-count":53,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-4738-7_16","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,1]]},"assertion":[{"value":"1 October 2025","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}